Aaron Hirschhorn, the founder of Gallant, appeared on Shark Tank in late 2019 looking for additional funding for the business. Having struggled with chronic back pain and being cured through stem cell and regenerative medicine, Hirschhorn looked to bring this healing therapy to dogs.
Anne Wojcicki and Lori Greiner went in together and funded $500,000 in exchange for 5% of the company. Gallant has at least another 7 Million in funding from earlier investors.
Having 4 key patents to offer protection from competitors and a history having owned Dog Vacay which was bought by Rover, Hirschhorn and his team are set up nicely to grow and control the dog stem cell therapy space.